Brannon Morisoli focuses on investing in the life sciences industry, building relationships with leading venture capital firms and supporting life sciences teams. [Illustration: courtesy photo, istockphoto]
California-based Runway Growth Capital, which provides growth loans to both venture and non-venture companies seeking alternatives to raising capital, announced the hiring of Brannon Morisoli as Managing Director of Life Sciences Did.
Based in Dallas, Morisori will continue to build relationships with leading VC firms that support top life sciences management teams, while expanding its bank and brokerage relationships. Runway’s industry partners include VCs, PE firms, investment and commercial banks.
Debt Equity Solutions for Life Sciences Companies
Morisori will focus on investing in the life sciences industry and build flexible debt-equity solutions that allow borrowers to focus on achieving their business goals, Runway said in a statement.
According to the company, the life sciences ecosystem is complex. That’s why it’s important to understand the difficult road from concept to commercialization.
Revitalize life sciences with venture debt that minimizes dilution
With the tagline “Another Growth Capital,” Runway Growth Capital seeks life sciences companies at the forefront of clinical development and healthcare innovation – companies advancing healthcare and improving patient outcomes. .
That capital can help companies focus on those results, Runway says. Typical loan amounts range from $10 million to $75 million for him, the company said, with proceeds typically used to extend runways, accelerate growth, refinance other debt, and finance acquisitions.
Morisori will report to Igor Dacruz, Managing Director of Life Sciences.
“Life Sciences continues to be a focus area for Runway. Brannon’s sector expertise, origination experience, and extensive life sciences network make him ideally positioned to continue the growth of this space. ‘ said DaCruz in a statement.
Morrisoli said the life sciences MD has a responsibility to “identify life sciences companies that can benefit from debt to strengthen their balance sheets and drive growth.”
Morisori Joins Life Science Team Amid DFW Boom
Morisori was drawn to Runway’s “rapid growth, strong brand and reputation as a great partner,” noting that it has a strong life sciences foundation. He joined his Life Sciences team at a time when Life Sciences was booming in North Texas. Recently, in his 2022 report for Commercial Edge, “Top 20 U.S. Large Cities for Life Sciences,” Dallas Fort His Worth was ranked for the first time.
Morisori previously served on the board of directors of SWK Holdings, focused on providing innovative capital solutions to a wide range of healthcare and life sciences companies.
Prior to that, he was an investment analyst at Presidium Group, where he played a key role in closings. $100 million In real estate PE company transactions.
An industry with a working knowledge of the life sciences and medical device fields, Morisori began his career as a researcher and has been published in leading neurology journals. He also gained operational experience while serving as his Manager of Marketing Services at his Neurografix, a venture-backed medical technology start-up.
Boston technology managing director also named
In addition to life sciences, Runway Growth Capital also serves technology and consumer industries.
The company also announced a new managing director of technology. Ted Cavan works outside of Boston and also reports to DaCruz. According to the company, Cavan will work with late- and growth-stage technology companies, with a focus on enterprise software.
entrepreneur’s partner
Runway Growth Capital LLC was founded in 2015 by industry veterans. David Spring Investment advisor for investment funds. Those include Runway Growth Finance Corporation (Nasdaq: RWAY), a business development firm, and other private funds that lend growth capital to companies in need instead of raising equity, according to the company. increase.
Runway works with fast-growing companies based in usa When CanadaSince its inception, the company has funded 61 companies and has signed $1.8 billion in commitments to date.
Quincy Preston contributed to this report.
Please be on the list.
Dallas continues to innovate every day.
Sign up for daily updates on what’s new in Dallas-Fort Worth plus:
read next
-
Vision2 Systems is a fast-growing online giving platform designed for churches with a $2.8 million investment for expansion.
-
Summit is an innovation multiplier for capital, collaboration, and commercialization. Plus, you can meet the 2021 NTX Rising Stars and new companies moving to BioLabs at Pegasus Park. Here’s the latest agenda for the annual iC3 Life Science Summit on September 30th and October 1st:
-
Two nonprofits will each receive a grant of $250,000. The Capital One grant is part of his $3.5 million effort for 12 nonprofits.
-
In this week’s roundup of jobs, promotions and accolades in North Texas, you’ll also find news from Firehouse, Enseo, Cambium Learning, D Magazine, Lear Investment Management, Spacee, Envy Gaming, 5Q, Stream Realty Partners, Nanoscope and Crossplane . Capital, Improving, TimelyMD, etc.
-
The deadline for nominations is Friday, September 17th. His 2021 award, sponsored by his BioLabs at Pegasus Park, will be presented at the iC3 Life Science Summit on September 30. The impact Dr. Dennis K. Stone has had on his DFW biotech industry is arguably immense, he said, BioNTX. Past recipients of this award honoring his memory are Phil Ralston, Lyda Hill, Darlene Boudreau, Paul Dorman and Hubert Zazicek.